These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 28642869)
1. Detection of MicroRNA in Hepatic Cirrhosis and Hepatocellular Carcinoma in Hepatitis C Genotype-4 in Egyptian Patients. Demerdash HM; Hussien HM; Hassouna E; Arida EA Biomed Res Int; 2017; 2017():1806069. PubMed ID: 28642869 [TBL] [Abstract][Full Text] [Related]
2. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients. Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924 [TBL] [Abstract][Full Text] [Related]
3. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients. Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740 [TBL] [Abstract][Full Text] [Related]
4. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients. Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226 [TBL] [Abstract][Full Text] [Related]
5. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma. El Mahdy HA; Abdelhamid IA; Amen AI; Abdelsameea E; Hassouna MM Asian Pac J Cancer Prev; 2019 Sep; 20(9):2723-2731. PubMed ID: 31554369 [TBL] [Abstract][Full Text] [Related]
7. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients. Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940 [TBL] [Abstract][Full Text] [Related]
8. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma. Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538 [TBL] [Abstract][Full Text] [Related]
9. A Potential Serum Higashi M; Yoshimura T; Usui N; Kano Y; Deguchi A; Tanabe K; Uchimura Y; Kuriyama S; Suzuki Y; Masaki T; Ikenaka K Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255418 [TBL] [Abstract][Full Text] [Related]
10. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma. Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432 [TBL] [Abstract][Full Text] [Related]
11. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C. Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822 [TBL] [Abstract][Full Text] [Related]
12. The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma. Soliman HH; Nagy H; Kotb N; Alm El-Din MA Int J Biol Markers; 2012 Jul; 27(2):e125-31. PubMed ID: 22388957 [TBL] [Abstract][Full Text] [Related]
13. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
14. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
15. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
16. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases. Ouda SM; Khairy AM; Sorour AE; Mikhail MN Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805 [TBL] [Abstract][Full Text] [Related]
17. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. Oksuz Z; Serin MS; Kaplan E; Dogen A; Tezcan S; Aslan G; Emekdas G; Sezgin O; Altintas E; Tiftik EN Mol Biol Rep; 2015 Mar; 42(3):713-20. PubMed ID: 25391771 [TBL] [Abstract][Full Text] [Related]
18. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients. Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493 [TBL] [Abstract][Full Text] [Related]
19. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection. Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876 [TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients. El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]